Posted February 28, 2014

Weight Loss Supplement Contains Undeclared Drug

On February 18, 2014, Health Canada warned consumers not to use weight loss supplement LV Shou Reduces Fat because it contains sibutramine.

Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.

LV Shou Reduces Fat is packaged in white plastic bottles containing white and green capsules. It is available for sale to U.S. consumers through major online retailers and through the company's website, www.lvshou.us/Product.

The warning also included weight loss supplements STB Summit of the Thin Body S Woman Degreasing Burning Pill and Lightning 10.0+ Reduces Weight; however, these products do not appear to be available for sale to U.S. consumers.

(See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.)

See Related Warnings:

Weight Loss Supplement Recall Expanded to Include Additional Products

Weight Loss Supplement Containing Drug Recalled

FDA Warns Consumers Of Weight Loss Supplement Containing Undeclared Drug

Weight Loss Supplement Recalled Due To Undeclared Drug

FDA Seizes Weight Loss Supplements Containing Undeclared Drug

Rx Drugs Found in Weight Loss and Enhancement Supplements

Recall of "Slimming" Supplements Spiked with Drug

To read Health Canada's warning, use the link below.